We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

ALIFAX DIAG/SRE

Develops automated diagnostic instruments for ESR testing and Bacterial Culture read more Featured Products: More products

Download Mobile App





Alifax Demonstrates Automated Solutions to Improve Performance in Laboratory Settings

By LabMedica International staff writers
Posted on 07 Feb 2024

At Medlab Middle East 2024, Alifax (Polverara, Italy) is showcasing its innovative solutions designed to enhance efficiency, accuracy, and reliability in laboratory settings. More...

Visitors to the Alifax booth can discover firsthand the company’s automated solutions: the new Test1 2.0 ESR system, I-dOne for fast ID, Molecular Mouse RT-PCR & Sepsis panel, fast phenotypic MDRO screening, and more, all engineered to deliver precise results that drive better patient outcomes. The Test1 2.0 ESR system is a new generation instrument from Alifax that is designed for ESR determination in less than 20 seconds. The new and updated Alifax analyzer allows testing of the ESR rate and overcomes the majority of the variables and limitations of the classical sedimentation method, thanks to the capillary photometry technology.

Alifax is also highlighting I-dOne which uses ATR-FTIR technology to identify the bacterial spectra, which can be considered as the molecular fingerprint of microorganisms. I-dOne analyzes the spectrum produced by the interaction between intact microbial cells and IR light through the vibrational state of their chemical bonds. Each species produces a unique fingerprint-like FTIR spectrum. Results are reported as Microorganism ID along with a relative score that represents the reliability of the identification to known vibrational profiles of species present in the reference database.

In addition, Alifax is showcasing the Molecular Mouse RT-PCR & Sepsis panel which provides qualitative and fast analysis of target molecules through real-time PCR and ready-to-use cartridges. The Molecular Mouse system is the world’s first handheld platform for the Real-Time PCR. It uses ready-to-use lab-on-chip cartridges, with all lyophilized reagents in each micro-well, making it possible to perform up to six simultaneous multiplex reactions. Alifax’s Sepsis panel is the largest panel, with 64 different targets, for the rapid detection of microorganisms of major clinical relevance and their antibiotic-resistance genes, starting from positive blood cultures.

Related Links:
Alifax


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Hematology Consumables
Bioblood Devices
New
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
MEDLAB 2024
Copyright © 2000-2026 Globetech Media. All rights reserved.